Evidence map›Paper›PMID 33584710›Full record

Observational studyFrontiers in immunology2020

Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency-Features of CT and

Mai Sasaki Aanensen Fraz, Natasha Moe, Mona-Elisabeth Revheim, Maria L Stavrinou, Michael T Durheim, Ingvild Nordøy, Magnhild Eide Macpherson, Pål Aukrust, Silje Fjellgård Jørgensen, Trond Mogens Aaløkken and 1 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Article
  4. Rare interstitial lung diseases: a narrative review.Journal of thoracic disease · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Mai Sasaki Aanensen FrazSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Natasha MoeDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Mona-Elisabeth RevheimDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Maria L StavrinouDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Michael T DurheimInstitute of Clinical Medicine, University of Oslo, Oslo, Norway.
Ingvild NordøySection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Magnhild Eide MacphersonSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Pål AukrustSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Silje Fjellgård JørgensenSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Trond Mogens AaløkkenDivision of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.
Børre FevangSection of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Common variable immunodeficiency (CVID) is characterized not only by recurrent bacterial infections, but also autoimmune and inflammatory complications including interstitial lung disease (ILD), referred to as granulomatous-lymphocytic interstitial lung disease (GLILD). Some patients with GLILD have waxing and waning radiologic findings, but preserved pulmonary function, while others progress to end-stage respiratory failure. We reviewed 32 patients with radiological features of GLILD from our Norwegian cohort of CVID patients, including four patients with possible monogenic defects. Nineteen had deteriorating lung function over time, and 13 had stable lung function, as determined by pulmonary function testing of forced vital capacity (FVC), and diffusion capacity of carbon monoxide (DLCO). The overall co-existence of other non-infectious complications was high in our cohort, but the prevalence of these was similar in the two groups. Laboratory findings such as immunoglobulin levels and T- and B-cell subpopulations were also similar in the progressive and stable GLILD patients. Thoracic computer tomography (CT) scans were systematically evaluated and scored for radiologic features of GLILD in all pulmonary segments. Pathologic features were seen in all pulmonary segments, with traction bronchiectasis as the most prominent finding. Patients with progressive disease had significantly higher overall score of pathologic features compared to patients with stable disease, most notably traction bronchiectasis and interlobular septal thickening. 18F-2-fluoro-2-deoxy-D-glucose ( Conclusion: Patients with progressive GLILD as defined by deteriorating pulmonary function had significantly greater pathology on pulmonary CT and FDG-PET CT scans as compared to patients with stable disease, with traction bronchiectasis and interlobular septal thickening as prominent features.

Indexed as

Common Variable ImmunodeficiencyDisease ProgressionFluorodeoxyglucose F18HumansLung Diseases, InterstitialPositron Emission Tomography Computed TomographyRespiratory Function TestsRespiratory InsufficiencyRetrospective StudiesFluorodeoxyglucose F18CVID- Common Variable Immunodeficiency DisordersDLCOFDG – PETGLILDInterstitial lung disease (ILD)Primary immumunodeficienciesPulmonary CTrituximab

Identifiers

PMID33584710
PMCPMC7874137
OpenAlexW3122099189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.